Table 1.
Characteristic | Hologic | GE | ||||||
---|---|---|---|---|---|---|---|---|
Cases | Cohort | Cases | Cohort | |||||
N | % | N | % | N | % | N | % | |
Total | 812 | 100.0 | 17,970 | 100.0 | 176 | 100.0 | 3180 | 100.0 |
Age at mammogram | ||||||||
40–49 | 43 | 5.3 | 1867 | 10.4 | 11 | 6.2 | 532 | 16.7 |
50–59 | 200 | 24.6 | 4837 | 26.9 | 48 | 27.3 | 965 | 30.4 |
60–69 | 383 | 47.2 | 7563 | 42.1 | 81 | 46.0 | 1265 | 39.8 |
70+ | 186 | 22.9 | 3703 | 20.6 | 36 | 20.5 | 418 | 13.1 |
Mammogram year | ||||||||
2004–2007 | 60 | 7.4 | 695 | 3.9 | 42 | 23.9 | 571 | 18.0 |
2008–2009 | 284 | 25.0 | 5235 | 29.1 | 122 | 69.3 | 2285 | 71.9 |
2010–2011 | 263 | 32.4 | 6605 | 36.8 | 12 | 6.8 | 300 | 9.4 |
2012–2013 | 205 | 25.2 | 5435 | 30.2 | 0 | 0 | 24 | 0.8 |
BMI | ||||||||
24 or less | 283 | 34.8 | 7020 | 39.1 | 74 | 42.0 | 1415 | 44.5 |
25–29 | 281 | 34.6 | 5871 | 32.7 | 62 | 35.2 | 1029 | 32.4 |
30–34 | 137 | 16.9 | 3081 | 17.1 | 26 | 14.8 | 489 | 15.4 |
35–39 | 60 | 7.4 | 1246 | 6.9 | 8 | 4.6 | 168 | 5.3 |
40+ | 51 | 6.3 | 752 | 4.2 | 6 | 3.4 | 79 | 2.5 |
First-degree family history of breast cancer | ||||||||
No | 714 | 87.9 | 16,498 | 91.8 | 155 | 88.1 | 2902 | 91.3 |
Yes | 98 | 12.1 | 1472 | 8.2 | 21 | 11.9 | 278 | 8.7 |
Use of postmenopausal hormonesa | ||||||||
None | 550 | 67.7 | 12,401 | 69.0 | 95 | 54.0 | 1886 | 59.3 |
Estrogen alone | 94 | 11.6 | 2095 | 11.7 | 26 | 14.8 | 460 | 14.5 |
Estrogen + progestin | 127 | 15.6 | 2287 | 12.7 | 49 | 27.8 | 563 | 17.7 |
Other | 41 | 5.1 | 1187 | 6.6 | 6 | 3.4 | 271 | 8.5 |
Parity | ||||||||
Nulliparous | 44 | 5.4 | 1087 | 6.0 | 17 | 9.7 | 247 | 7.8 |
Parous | 645 | 79.4 | 13,959 | 77.7 | 127 | 72.2 | 2308 | 72.6 |
Missing | 123 | 15.2 | 2924 | 16.3 | 32 | 18.2 | 625 | 19.6 |
aWithin 5 years prior to mammogram date